In medial collateral ligament (MCL) injury models, BPC-157 administered intraperitoneally (10 g or 10 ng/kg once daily), topically as a cream layer, or orally in drinking water consistently produced functional, biomechanical, macroscopic, and histological healing improvements throughout the 90-day study period
But I'm left with even more questions"
Malti Vij, an internal medicine physician
Every one of these mechanistic claims, however, rests on animal and in-vitro data there is no human mechanistic confirmation
Also read: Foundayo (orforglipron) Wins FDA Approval as First Anytime GLP1 Tablet for Weight Loss Q2 REVENUES: Johnson & Johnson reported solid financial performance for the second quarter of 2026, with total sales rising 6.6% year-over-year to reach $25.3 billion
Kvicala, J